GALECTIN THERAPEUTICS INC. Shareholders' Equity
GALECTIN THERAPEUTICS INC. (GALT) had Shareholders' Equity of -$138.57 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent -$138.57M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$131.96M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$127.92M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$125.30M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$138.57M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$131.96M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | -$127.92M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | -$125.30M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$118.89M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | -$113.98M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | -$104.79M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | -$94.20M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | -$83.87M 10-Q · filed 2025-11-14 | |
| 2024-03-31 | -$44.37M 10-Q · filed 2025-08-14 | -$72.81M 10-Q · filed 2024-05-15 |
| 2023-12-31 | -$61.96M 10-K · filed 2026-03-31 | |
| 2023-09-30 | -$52.60M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$52.85M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | -$44.37M 10-Q · filed 2024-08-13 | |
| 2022-12-31 | -$33.92M 10-K · filed 2025-03-31 | |
| 2022-09-30 | -$24.06M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | -$16.95M 10-Q · filed 2023-11-13 | |
| 2022-03-31 | -$7.92M 10-Q · filed 2023-08-14 | |
| 2021-12-31 | $893.00K 10-K · filed 2024-03-29 | |
| 2021-09-30 | $7.53M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $15.39M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $16.51M 10-Q · filed 2022-08-15 | |
| 2020-12-31 | $22.47M 10-K · filed 2023-03-30 | |
| 2020-09-30 | $29.82M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $35.29M 10-Q · filed 2021-11-15 | $35.29M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $41.03M 10-Q · filed 2021-08-16 | |
| 2019-12-31 | $43.87M 10-K · filed 2022-03-31 | |
| 2019-09-30 | $47.76M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $49.90M 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $5.12M 10-Q · filed 2020-08-10 | |
| 2018-12-31 | $5.17M 10-K · filed 2021-03-31 | |
| 2018-09-30 | $7.25M 10-Q · filed 2019-11-12 | $7.25M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $8.05M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $925.00K 10-Q · filed 2019-08-09 | |
| 2017-12-31 | -$530.00K 10-K · filed 2020-03-16 | |
| 2017-09-30 | $947.00K 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $4.09M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $7.91M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $10.29M 10-K · filed 2019-03-06 | |
| 2016-09-30 | $10.30M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $7.49M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $12.47M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $18.04M 10-K · filed 2018-03-29 | |
| 2015-09-30 | $12.84M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $17.88M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $21.85M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $21.20M 10-K · filed 2017-03-28 | |
| 2014-09-30 | $23.22M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $25.72M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $28.27M 10-Q · filed 2014-05-13 | |
| 2013-12-31 | $1.48M 10-K · filed 2016-03-15 | |
| 2013-09-30 | $1.30M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | -$3.09M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | -$1.04M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $1.17M 10-K · filed 2016-03-15 | |
| 2012-09-30 | $3.06M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $4.91M 10-Q · filed 2012-08-10 | |
| 2012-03-31 | $6.82M 10-Q · filed 2012-05-11 | |
| 2011-12-31 | -$2.13M 10-K · filed 2015-03-18 | |
| 2011-09-30 | $823.00K 10-Q · filed 2011-11-10 | |
| 2011-06-30 | $915.00K 10-Q · filed 2011-08-12 | |
| 2010-12-31 | -$1.69M 10-K · filed 2013-03-29 | |
| 2009-12-31 | -$4.47M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |